Correlation and efficacy of TACE combined with lenvatinib plus PD‐1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features

BACKGROUND: Although the appearance of portal vein tumor thrombus (PVTT) is significantly associated with unfavorable prognosis, there is insufficient evidence to confirm the efficacy and safety of the triple combination of transarterial chemoembolization (TACE), lenvatinib, and programmed cell deat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Xinhua, Xu, Qingyu, You, Ran, Yin, Guowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242346/
https://www.ncbi.nlm.nih.gov/pubmed/36951443
http://dx.doi.org/10.1002/cam4.5841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242346/
https://www.ncbi.nlm.nih.gov/pubmed/36951443
http://dx.doi.org/10.1002/cam4.5841

Ejemplares similares